Analysis

Pharmaceutical titan Eli Lilly & Co. finds itself at the center of a Wall Street debate, presenting investors with a...

Compass Therapeutics has captured market attention through a combination of promising clinical data and strategic financial maneuvers. While analyst sentiment...

Shares of semiconductor testing equipment maker Aehr Test have been on a remarkable rollercoaster ride, propelled by soaring demand for...

The recent performance of 10X Genomics (TXG) presents investors with a fascinating puzzle: how can a company deliver impressive quarterly...

While numerous regional financial institutions adopt defensive postures, Independent Bank Corp. is taking a decidedly proactive approach. The company is...

Almonty Industries has reported deeply disappointing financial results for the second quarter of 2025, sending shockwaves through the market. The...

While Bitcoin and other major cryptocurrencies posted gains in today's trading session, Ethereum's price performance lagged behind. This short-term price...

The iShares MSCI Germany ETF is navigating a complex economic landscape. Germany's equity market is confronting significant pressures from a...

Ryohin Keikaku Co., the operator of the MUJI retail brand, finds itself in a curious market position. The company continues...

Corbus Pharmaceuticals shares edged higher in after-hours trading, reaching $9.93 after closing at $9.74—a gain of nearly 2 percent. Investor...